Literature DB >> 22943550

Effect of halofantrine on QT interval in children.

Jean-Yves Siriez1, Jean-Marc Lupoglazoff, Marie-Laure Bouchy-Bagros, Lauren Pull, Isabelle Denjoy.   

Abstract

In order to assess cardiac tolerance of halofantrine in children, we studied, retrospectively, 15 non complicated falciparum malaria cases treated with halofantrine, and focused on the effect on ventricular repolarisation. Our data showed that halofantrine can produce a moderate QTc prolongation without any life-threatening arrhythmia. As long as contraindications of the drug are respected, this treatment should be considered as a therapeutical option in young children presenting with non complicated falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943550      PMCID: PMC4001500          DOI: 10.1179/2047773212Y.0000000007

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  5 in total

Review 1.  Mechanism of cardiotoxicity of halofantrine.

Authors:  D L Wesche; B G Schuster; W X Wang; R L Woosley
Journal:  Clin Pharmacol Ther       Date:  2000-05       Impact factor: 6.875

2.  Cardiac effects of antimalarial treatment with halofantrine.

Authors:  F Nosten; F O ter Kuile; C Luxemburger; C Woodrow; D E Kyle; T Chongsuphajaisiddhi; N J White
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

3.  Sudden deaths while on halofantrine treatments--a report of two cases from peshawar.

Authors:  T Akhtar; M Imran
Journal:  J Pak Med Assoc       Date:  1994-05       Impact factor: 0.781

4.  [Cardiac rhythm disturbances and prolonged QT interval with halofantrine].

Authors:  I Lavallée; E Marc; F Moulin; J M Treluyer; P Imbert; D Gendrel
Journal:  Arch Pediatr       Date:  2001-08       Impact factor: 1.180

Review 5.  Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base.

Authors:  Olivier Bouchaud; Patrick Imbert; Jean Etienne Touze; Alex N O Dodoo; Martin Danis; Fabrice Legros
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.